Hosted on MSN1mon
A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseasesBB1 treatment activates the toll-like receptor (TLR)-2/TLR-6 signaling pathway, leading to the activation of peroxisome proliferator-activated receptor γ (PPAR- γ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback